AU2002357164A1 - Pyrazolopyridazine derivatives - Google Patents
Pyrazolopyridazine derivativesInfo
- Publication number
- AU2002357164A1 AU2002357164A1 AU2002357164A AU2002357164A AU2002357164A1 AU 2002357164 A1 AU2002357164 A1 AU 2002357164A1 AU 2002357164 A AU2002357164 A AU 2002357164A AU 2002357164 A AU2002357164 A AU 2002357164A AU 2002357164 A1 AU2002357164 A1 AU 2002357164A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrazolopyridazine derivatives
- pyrazolopyridazine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NMEPLWZDUIIAAC-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]pyridazine Chemical class C1=NN=C2C=NNC2=C1 NMEPLWZDUIIAAC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34179801P | 2001-12-17 | 2001-12-17 | |
| US60/341,798 | 2001-12-17 | ||
| PCT/US2002/039672 WO2003051886A1 (en) | 2001-12-17 | 2002-12-11 | Pyrazolopyridazine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002357164A8 AU2002357164A8 (en) | 2003-06-30 |
| AU2002357164A1 true AU2002357164A1 (en) | 2003-06-30 |
Family
ID=23339081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002357164A Abandoned AU2002357164A1 (en) | 2001-12-17 | 2002-12-11 | Pyrazolopyridazine derivatives |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7279473B2 (enExample) |
| EP (1) | EP1463730B1 (enExample) |
| JP (1) | JP2005524609A (enExample) |
| AR (1) | AR037826A1 (enExample) |
| AT (1) | ATE323706T1 (enExample) |
| AU (1) | AU2002357164A1 (enExample) |
| DE (1) | DE60210819T2 (enExample) |
| ES (1) | ES2262899T3 (enExample) |
| TW (1) | TW200301119A (enExample) |
| WO (1) | WO2003051886A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4291696B2 (ja) | 2002-01-22 | 2009-07-08 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 2−(ピリジン−2−イルアミノ)−ピリド[2,3−d]ピリミジン−7−オン |
| JP2006504755A (ja) * | 2002-10-15 | 2006-02-09 | スミスクライン ビーチャム コーポレーション | Gsk−3阻害薬としてのピリダジン化合物 |
| JP4053073B2 (ja) * | 2003-07-11 | 2008-02-27 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 選択的cdk4阻害剤のイセチオン酸塩 |
| DE10344223A1 (de) * | 2003-09-24 | 2005-04-21 | Merck Patent Gmbh | 1,3-Benzoxazolylderivate als Kinase-Inhibitoren |
| WO2006050076A1 (en) | 2004-10-29 | 2006-05-11 | Janssen Pharmaceutica, N.V. | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| JP2009507032A (ja) | 2005-09-02 | 2009-02-19 | アボット・ラボラトリーズ | 新規なイミダゾ系複素環 |
| WO2008068171A1 (en) * | 2006-12-08 | 2008-06-12 | F. Hoffmann-La Roche Ag | Substituted pyrimidines and their use as jnk modulators |
| KR20100098521A (ko) * | 2007-12-07 | 2010-09-07 | 노파르티스 아게 | 피라졸 유도체 및 그의 사이클린 의존성 키나제 억제제로서의 용도 |
| HRP20170317T1 (hr) | 2008-02-15 | 2017-04-21 | Rigel Pharmaceuticals, Inc. | Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza |
| TW201433568A (zh) * | 2008-06-30 | 2014-09-01 | Janssen Pharmaceutica Nv | 製備經取代之嘧啶衍生物的方法 |
| AR074870A1 (es) * | 2008-12-24 | 2011-02-16 | Palau Pharma Sa | Derivados de pirazolo (1,5-a ) piridina |
| JP5959537B2 (ja) * | 2011-01-28 | 2016-08-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ピリジニル−ピリミジン及び医薬としてのその使用 |
| US20150203812A1 (en) * | 2014-01-20 | 2015-07-23 | Francesco Tombola | Inhibitors of Voltage Gated Ion Channels |
| GB201605126D0 (en) * | 2016-03-24 | 2016-05-11 | Univ Nottingham | Inhibitors and their uses |
| CN106699608A (zh) * | 2016-12-26 | 2017-05-24 | 常州大学 | 一种含有强吸电子基团的苯胍及其盐的制备方法 |
| GB201715342D0 (en) * | 2017-09-22 | 2017-11-08 | Univ Nottingham | Compounds |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
| WO2020180959A1 (en) | 2019-03-05 | 2020-09-10 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
| US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| WO2021003517A1 (en) * | 2019-07-10 | 2021-01-14 | Aucentra Therapeutics Pty Ltd | Derivatives of 4-(imidazo[l,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin- 2-amine as therapeutic agents |
| PH12022550361A1 (en) | 2019-08-14 | 2023-02-27 | Incyte Corp | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| PE20221905A1 (es) | 2019-10-11 | 2022-12-23 | Incyte Corp | Aminas biciclicas como inhibidoras de la cdk2 |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| WO2023107705A1 (en) | 2021-12-10 | 2023-06-15 | Incyte Corporation | Bicyclic amines as cdk12 inhibitors |
| CN118005948B (zh) * | 2024-04-09 | 2024-06-28 | 蓝固(湖州)新能源科技有限公司 | 一种电解液添加剂及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU622330B2 (en) | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
| AU734009B2 (en) * | 1997-05-30 | 2001-05-31 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
| ATE281458T1 (de) | 1997-09-05 | 2004-11-15 | Glaxo Group Ltd | Pharmazeutische zusammensetzung, enthaltend 2,3- diaryl-pyrazolo(1,5-b)pyridazin derivate |
| WO1999032447A2 (en) | 1997-12-11 | 1999-07-01 | American Home Products Corporation | 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof |
| GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
| KR20010089805A (ko) | 1999-11-10 | 2001-10-08 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 치환된 2-아릴-3-(헤테로아릴)-이미다조[1,2-a]피리미딘,및 관련 약제학적 조성물 및 방법 |
| AU2001296871A1 (en) | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
-
2002
- 2002-12-11 ES ES02805104T patent/ES2262899T3/es not_active Expired - Lifetime
- 2002-12-11 US US10/499,179 patent/US7279473B2/en not_active Expired - Fee Related
- 2002-12-11 WO PCT/US2002/039672 patent/WO2003051886A1/en not_active Ceased
- 2002-12-11 AU AU2002357164A patent/AU2002357164A1/en not_active Abandoned
- 2002-12-11 AT AT02805104T patent/ATE323706T1/de not_active IP Right Cessation
- 2002-12-11 EP EP02805104A patent/EP1463730B1/en not_active Expired - Lifetime
- 2002-12-11 JP JP2003552768A patent/JP2005524609A/ja active Pending
- 2002-12-11 DE DE60210819T patent/DE60210819T2/de not_active Expired - Fee Related
- 2002-12-13 TW TW091136132A patent/TW200301119A/zh unknown
- 2002-12-13 AR ARP020104845A patent/AR037826A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2262899T3 (es) | 2006-12-01 |
| JP2005524609A (ja) | 2005-08-18 |
| EP1463730A1 (en) | 2004-10-06 |
| DE60210819T2 (de) | 2007-04-19 |
| ATE323706T1 (de) | 2006-05-15 |
| US20050090507A1 (en) | 2005-04-28 |
| AU2002357164A8 (en) | 2003-06-30 |
| WO2003051886A8 (en) | 2004-08-19 |
| TW200301119A (en) | 2003-07-01 |
| EP1463730B1 (en) | 2006-04-19 |
| DE60210819D1 (en) | 2006-05-24 |
| US7279473B2 (en) | 2007-10-09 |
| AR037826A1 (es) | 2004-12-09 |
| WO2003051886A1 (en) | 2003-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002357164A1 (en) | Pyrazolopyridazine derivatives | |
| AU2002349676A1 (en) | 4-oxoquinoline derivatives | |
| AU2002313565A1 (en) | Putter-heads | |
| AU2002358715A1 (en) | Tetrahydrobenzfluorene derivatives | |
| AU2002313943A1 (en) | Electromobile | |
| AU2002226571A1 (en) | Biligands | |
| AU2001100406A4 (en) | DriverSMS | |
| AU2002313073A1 (en) | Phytocystatin | |
| AU2002257925A1 (en) | Numberplates | |
| AU2002255269B8 (en) | 2-Iminopyrrolidine derivatives | |
| AU2001100522A4 (en) | e-Trans | |
| AU2001100532A4 (en) | FonePark | |
| AU2001100338A4 (en) | Sunglove | |
| AU2001100214A4 (en) | Dolly-trolley | |
| AU2002100746A4 (en) | Adrail | |
| AU2002255269A1 (en) | 2-Iminopyrrolidine derivatives | |
| AU2002354530A1 (en) | 4-phenylpyran-2-one derivatives | |
| AU2002225034A1 (en) | Rustmicin derivatives | |
| AU2002350425A1 (en) | 6-phenyldihydropyrrolopyrimidinedione derivatives | |
| AU2002325368A1 (en) | Benzoylcyclohexenone derivatives | |
| AU2002249205A1 (en) | Bis-triazinylaminobenzoxazole derivatives | |
| HK1062431A (en) | A-amino-n-hydroxy-acetamide derivatives | |
| AU2002230196A1 (en) | Dicarba-closo-dodecarborane derivatives | |
| AU2002253080A1 (en) | Biurethane derivatives | |
| AU2002305184A1 (en) | Cycloalkenylsulfonamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |